CN Patent

CN101032483B — 调节雄激素受体活性的乙内酰脲衍生物及其应用

Assigned to Individual · Expires 2011-05-04 · 15y expired

What this patent protects

本发明提供了新的乙内酰脲HYDANTOIN衍生物的药物组成，合成过程，以及它们的医学应用，由于这些化合物对雄激素受体有调节作用，它们可用于治疗前列腺癌或与雄激素受体有关的其他疾病和生理紊乱。

USPTO Abstract

本发明提供了新的乙内酰脲HYDANTOIN衍生物的药物组成，合成过程，以及它们的医学应用，由于这些化合物对雄激素受体有调节作用，它们可用于治疗前列腺癌或与雄激素受体有关的其他疾病和生理紊乱。

Drugs covered by this patent

Patent Metadata

Patent number
CN101032483B
Jurisdiction
CN
Classification
—
Expires
2011-05-04
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.